APA Alıntı

Yap, T. A., Kristeleit, R., Michalarea, V., Pettitt, S. J., Lim, J. S., Carreira, S., . . . de Bono, J. S. (2020). Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers. Cancer Discov.

Chicago Stili Alıntı

Yap, Timothy A., et al. "Phase I Trial of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor olaparib and AKT Inhibitor Capivasertib in Patients With BRCA1/2 and Non-BRCA1/2 Mutant cancers." Cancer Discov 2020.

MLA Alıntı

Yap, Timothy A., et al. "Phase I Trial of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor olaparib and AKT Inhibitor Capivasertib in Patients With BRCA1/2 and Non-BRCA1/2 Mutant cancers." Cancer Discov 2020.